3rd Quarter - Report

COUNCIL FOR RESPONSIBLE NUTRITION for COUNCIL FOR RESPONSIBLE NUTRITION

Firm
Client
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Monitored the NDAA for any issues related to the dietary supplements industry.

LobbyistCovered position, as disclosed
JULIA L GUSTAFSON —
MICHAEL DAVID MEIROVITZ —
STEVEN MISTER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

All legislative proposals related to the inclusion of dietary supplement purchases within tax-deductible Health Savings Accounts and Flexible Spending Accounts (HSAs/FSAs), including H.R. 4794, the Dietary Supplements Access Act and S.3172, A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products and foods for special dietary uses as qualified medical expenses.

LobbyistCovered position, as disclosed
JULIA L GUSTAFSON —
MICHAEL DAVID MEIROVITZ —
STEVEN MISTER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3172 (118th), H.R. 4794 (118th)

Consumer Issues/Safety/Products CSP

Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. H.R. 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. Issues related to nutritional access for underserved populations. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. Issues related to proposed FDA reorganization. Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. General issues related to the dietary supplements industry.

LobbyistCovered position, as disclosed
JULIA L GUSTAFSON —
MICHAEL DAVID MEIROVITZ —
STEVEN MISTER —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1629 (118th)

Health Issues HCR

H.R. 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. Issues related to proposed FDA reorganization. General issues related to the dietary supplements industry.

LobbyistCovered position, as disclosed
JULIA L GUSTAFSON —
MICHAEL DAVID MEIROVITZ —
STEVEN MISTER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 1629 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.